Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19

被引：6
|
作者：
Chewcharat, Api [1 ]
Chang, Yuan-Ting [2 ]
Sise, Meghan E. [3 ]
Bhattacharyya, Roby P. [4 ]
Murray, Megan B. [5 ,6 ]
Nigwekar, Sagar U. [3 ]
机构：
[1] Harvard Med Sch, Dept Med, Mt Auburn Hosp, Cambridge, MA USA
[2] Univ Edinburgh, Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland
[3] Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02115 USA
[4] Harvard Med Sch, Div Infect Dis, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA
[5] Harvard Med Sch, Depy Global Hlth & Social Med, Boston, MA 02115 USA
[6] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 01期
关键词：
D O I：
10.1016/j.ekir.2020.10.010
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：196 / 199
页数：4
相关论文
共 50 条
  • [31] Methodological Analysis: Randomized Controlled Trials for Pfizer and Moderna COVID-19 Vaccines
    Hallas, Donna
    Spratling, Regena
    Fletcher, Jason
    [J]. JOURNAL OF PEDIATRIC HEALTH CARE, 2020, 35 (04) : 443 - 448
  • [32] REMDESIVIR FOR THE TREATMENT OF COVID-19: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Musa, Arif
    Warbasse, Elizabeth
    Yousif, Jenna
    Baron, David
    Stevens, Susan
    Blodget, Emily
    Pendi, Kasim
    Hashemi, Areio
    Aly, Besma
    Khambati, Alisha
    Tajran, Jahan
    Paradela, Danielle Rangel
    Chen, Daniel H.
    Kamal, Khalid
    Kouyoumjian, Sarkis
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S157 - S158
  • [33] Looking beyond COVID-19 vaccine phase 3 trials
    Jerome H. Kim
    Florian Marks
    John D. Clemens
    [J]. Nature Medicine, 2021, 27 : 205 - 211
  • [34] Looking beyond COVID-19 vaccine phase 3 trials
    Kim, Jerome H.
    Marks, Florian
    Clemens, John D.
    [J]. NATURE MEDICINE, 2021, 27 (02) : 205 - 211
  • [35] COVID-19: A Catalyst for Transforming Randomized Trials
    Lee, Jennifer J.
    Price, Jerri C.
    Jackson, William M.
    Whittington, Robert A.
    Ioannidis, John P. A.
    [J]. JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2022, 34 (01) : 107 - 112
  • [36] Exclusion of Persons with Kidney Disease in Trials of Peripheral Artery Disease A Systematic Review of Randomized Trials
    Wen, Yumeng
    Potok, O. Alison
    Wei, Xin
    Paranjpe, Ishan
    Chan, Lili
    Malhotra, Rakesh
    Coca, Steven
    Narula, Jagat
    Olin, Jeffrey W.
    Nadkarni, Girish N.
    Garimella, Pranav S.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (01): : 117 - 119
  • [37] Can we really trust the findings of the COVID-19 research? Quality assessment of the randomized controlled trials published on COVID-19
    Joshy, Athira S.
    Surendran, Saphal
    Undela, Krishna
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 158 - 158
  • [38] COVID-19 vaccines and kidney disease
    Martin Windpessl
    Annette Bruchfeld
    Hans-Joachim Anders
    Holly Kramer
    Meryl Waldman
    Laurent Renia
    Lisa F. P. Ng
    Zhou Xing
    Andreas Kronbichler
    [J]. Nature Reviews Nephrology, 2021, 17 : 291 - 293
  • [39] Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Muhammad Ehsan
    Uzair Jafar
    Momina Butt
    Aiman Naveed
    Mohammad Umer
    Muhammad Ayyan
    Biah Mustafa
    Rehmat Ullah Awan
    [J]. Journal of Thrombosis and Thrombolysis, 2023, 56 : 495 - 498
  • [40] COVID-19 and chronic kidney disease
    Trevino-Becerra, Alejandro
    Grajales-Garcia, Dulce P.
    Feria Ramirez, Jose A.
    [J]. GACETA MEDICA DE MEXICO, 2022, 158 : 45 - 47
12345